Peripheral FLT-3 ligand levels as a pathobiological parameter duringthe clinical course of acute myeloid leukemia.

Journal: Turkish journal of medical sciences
Published Date:

Abstract

BACKGROUND/AIM: FLT-3 ligand is a growth factor affecting the hematopoietic lineage. The aim of this study was to evaluate the variability of peripheral FLT-3 ligand during the clinical course of acute myeloid leukemia (AML) patients.

Authors

  • Memduh Şahin
    Department of Gastroenterology, Mersin State Hospital, Mersin, Turkey.
  • İbrahim Celalettin Haznedaroğlu
    Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Demircan Özbalcı
    Department of Hematology, Mersin State Hospital, Mersin, Turkey.